Codexis to Present at 2013 UBS Global Healthcare Conference
2013 UBS Global Healthcare Conference
REDWOOD CITY, Calif. -- May 14, 2013
Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for
pharmaceutical, biofuel and chemical production, today announced that John
Nicols, President and CEO of Codexis, will present a company overview at the
2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 3:00 p.m. ET
in New York City.
A live webcast and replay will be available on the Investors section of the
company's website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. engineers enzymes for pharmaceutical, biofuel and chemical
production. Codexis’ proven technology enables scale-up and implementation of
biocatalytic solutions to meet customer needs for rapid, cost-effective and
sustainable process development – from research to manufacturing. For more
information, see www.codexis.com.
Paul Cox, 212-362-1200
Jemma Connor, +44 161 359 3255
Press spacebar to pause and continue. Press esc to stop.